Retinoblastoma
Retinoblastoma is a malignant tumor of the eye that originates from the retina. It can affect one or both eyes in children, and is typically diagnosed in those 5 years old or younger.
This rare cancer of the eye is caused by a gene abnormality in chromosomes that contain genetic code that control cell growth and development. Most cases of retinoblastoma appear without warning or family precedent. Around 40 percent of children with retinoblastoma have an inherited form of the tumor, even if it has not presented in any other member of the family. Ten percent have a family member with the disease.
Retinoblastoma is detected using a CT scan and/or eye ultrasound. Other tests, such as an MRI or blood work, may be administered as well. An oncologist (doctor who specializes in cancer treatment) is often included in diagnosis and treatment.
Retinoblastoma is one of the most curable of childhood cancers, with 95 percent surviving. Prognosis depends on size and location of the tumor or tumors.
Treatment options include:
- Laser therapy: laser light is used to destroy the tumor.
- Cryotherapy: freezing treatment is used to destroy the tumor.
- Chemotherapy: drug treatment given via the bloodstream is used to kill the cancer cells; it is sometimes used in conjunction with laser therapy.
- Radiotherapy: high energy radiation is used to destroy cancer cells.
- Enucleation: removal of the eye.
Source: American Association for Pediatric Ophthalmology and Strabismus
Children’s Eye Care provides this information for general educational purposes only. It should not be construed as personal medical advice. Information published on this website is not intended to replace, supplant, or augment a consultation with an eye care professional. Children’s Eye Care disclaims any and all liability for injury or other damages that could result from use of the information obtained from this site.
SCHEDULE AN APPOINTMENT
RELATED POSTS
What’s new with pediatric glaucoma
Winner of the 2019 Richard Scobee Award
Lauren Marozas, CO, COT won the 2019 Richard G. Scobee Memorial Award. This national recognition is given to the orthoptist, and training program, who received the highest written and oral scores on that year’s board certification. Prior to joining CEC’s orthoptic training program, Lauren completed her BS in neuroscience at University of Michigan – Ann Arbor. Her orthoptic training consisted of
Oct. 15, 2019
Winner of the 2015 Richard G. Scobee Memorial Award
Nina Palomba, CO, COA won the 2015 Richard G. Scobee Memorial Award. This national recognition is given to the orthoptist, and training program, who received the highest written and oral scores on that year’s board certification. Ms. Palomba joined Children’s Eye Care in 2011 as an ophthalmic tech-trainee a year after completing her BS in child development at Central Michigan University.
Nov. 18, 2015
Stephen Burwell completes CEC’s Orthoptic Program
We are proud to announce that our orthoptic student has successful completed our two year orthoptic training program. Stephen Burwell, BS, COT has completed the intensive program as well as passed his written and oral boards with the American Orthoptic Council to become a board-certified orthoptist. He will then join Children’s Eye Care as a staff orthoptist. Congratulations to Stephen
Sep. 17, 2016
Children’s Eye Care Recognized as Quickest New Research Site Start-up
Susie (our research coordinator), Dr Bohra and Dr Gianfermi representing Children’s Eye Care, and accepting recognition for fastest new research clinic site start-up, at the Pediatric Eye Disease Investigator Group meeting.
Feb. 13, 2016
view all articles